In summary, compared to HD, iCAD patients were characterised by higher frequencies of CD14+CD16+ inflammatory monocytes, Treg cells, greater differentiation of CD4+ T cells (TEM and TEMRA), and general activation of NK and T cells and their subsets (Figure 2, Table 2 and Tables S4–S7). The gene discussed is CD14; the disease is Huntington disease.